Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BTC pulls back as US stocks open

BTC pulls back as US stocks open

Bitget2024/12/26 22:26

BTC is currently pulling back to $95,600 as US stocks open with market liquidity still low, MSTR, SMLR, and MARA are all down pre-market. Market sentiment is low and is expected to continue until the end of New Year's Day, but the general trend has not changed and Q1 2025 is something to look forward to. Nonetheless, the market is optimistic about cryptocurrency legislation in 2025, with the US Congress expected to prioritise key issues such as stablecoin and the FIT21 Act. Trump has repeatedly pledged support for cryptocurrencies since his election as president, and 2025 is expected to be the most supportive term for the crypto industry to date. Furthermore, corporations using their equity to follow MicroStrategy's lead and add Bitcoin to their balance sheets could become a major trend in 2025. However, there are some risks to the market, such as the U.S. debt problem and the Federal Reserve's monetary policy. The expectation of the number of Fed rate cuts in 2025 has been digested, but long-term interest rates rising too fast could hit the market. Overall, the cryptocurrency market in 2025 is full of opportunities and challenges, and investors need to remain cautious and keep a close eye on the market dynamics.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny